kresmion.
Pull a receipt

Avenue Therapeutics, Inc. (ATXI)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.43
As of

Kresmion compiles this page from ATXI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

AVENUE THERAPEUTICS, INC. (ATXI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-06.

As of . Source: SEC EDGAR filings for ATXI. Method and limitations.

COMPANY DOSSIER

See the full ATXI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ATXI on one page. Preview it with sample data, then open it live with a free account.

Preview the ATXI dossier

Active events for ATXI

  • mediumEarnings below estimates

    Q1-2024: Missed consensus by 67.8% - EPS $-15.4 vs $-9.18 estimate

    All 2026-06-23 events →
  • mediumEarnings below estimates

    Q2-2024: Missed consensus by 500.4% - EPS $-6.43 vs $-1.071 estimate

    All 2026-06-23 events →
  • mediumEarnings below estimates

    Missed consensus by 67.8% - EPS $-15.4 vs $-9.18 estimate

    All 2026-05-31 events →
  • mediumEarnings below estimates

    Missed consensus by 500.4% - EPS $-6.43 vs $-1.071 estimate

    All 2026-05-31 events →
  • mediumEarnings below estimates

    Q3-2024: Missed consensus by 100.3% - EPS $-1.92 vs $-0.9588 estimate

    All 2026-05-31 events →

FREE, NO ACCOUNT

Every event on ATXI, as it fires

New filings, 13F moves and cross asset events on ATXI land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, ATXI

Going concern statement

ATXI's 10-Q filed Nov 6, 2026 states:

However, as described below, substantial doubt about the Company's ability to continue as a going concern exists.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on ATXI

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in ATXI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ATXI in the last 180 days.

Upstream: SEC EDGAR filings for ATXI

Kresmion, "AVENUE THERAPEUTICS, INC. (ATXI) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/ATXI. Upstream data: SEC EDGAR filings for ATXI.

Link to this data (HTML):

<a href="https://kresmion.com/research/ATXI">AVENUE THERAPEUTICS, INC. (ATXI) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow ATXI on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ATXI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the ATXI dossier
Share

The ATXI intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.